Influence of fluoxetine on olanzapine pharmacokinetics.
- Published in:
- AAPS Journal, 2002, v. 4, n. 2, p. 56, doi. 10.1208/ps040209
- By:
- Publication type:
- Article
Works matching IS 15507416 AND DT 2002 AND VI 4 AND IP 2
Results: 7
1
2
cDNA Microarray analysis of vascular gene expression after nitric oxide donor infusion in rats: Implications for nitrate tolerance mechanisms.
- Published in:
- AAPS Journal, 2002, v. 4, n. 2, p. 45, doi. 10.1208/ps040208
- By:
- Publication type:
- Article
3
Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
- Published in:
- AAPS Journal, 2002, v. 4, n. 2, p. 34, doi. 10.1208/ps040207
- By:
- Publication type:
- Article
4
Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans.
- Published in:
- AAPS Journal, 2002, v. 4, n. 2, p. 24, doi. 10.1208/ps040206
- By:
- Publication type:
- Article
5
Assuring quality and performance of sustained and controlled release parenterals: Workshop report.
- Published in:
- AAPS Journal, 2002, v. 4, n. 2, p. 13, doi. 10.1208/ps040205
- By:
- Publication type:
- Article
6
Novel system to investigate the effects of inhaled volume and rates of rise in simulated inspiratory air flow on fine particle output from a dry powder inhaler.
- Published in:
- AAPS Journal, 2002, v. 4, n. 2, p. 7, doi. 10.1208/ps040211
- By:
- Publication type:
- Article
7
Pharmacogenomics: The implementation phase.
- Published in:
- AAPS Journal, 2002, v. 4, n. 2, p. 1, doi. 10.1208/ps040210
- By:
- Publication type:
- Article